616 related articles for article (PubMed ID: 16980240)
1. Targeting DNA methylation in cancer.
Szyf M
Bull Cancer; 2006 Sep; 93(9):961-72. PubMed ID: 16980240
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic tête-à-tête: the bilateral relationship between chromatin modifications and DNA methylation.
D'Alessio AC; Szyf M
Biochem Cell Biol; 2006 Aug; 84(4):463-76. PubMed ID: 16936820
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation and demethylation as targets for anticancer therapy.
Szyf M
Biochemistry (Mosc); 2005 May; 70(5):533-49. PubMed ID: 15948707
[TBL] [Abstract][Full Text] [Related]
5. DNA demethylation and cancer: therapeutic implications.
Szyf M; Pakneshan P; Rabbani SA
Cancer Lett; 2004 Aug; 211(2):133-43. PubMed ID: 15219937
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic mechanisms in glioblastoma multiforme.
Nagarajan RP; Costello JF
Semin Cancer Biol; 2009 Jun; 19(3):188-97. PubMed ID: 19429483
[TBL] [Abstract][Full Text] [Related]
7. DNA hypermethylation as a chemotherapy target.
Ren J; Singh BN; Huang Q; Li Z; Gao Y; Mishra P; Hwa YL; Li J; Dowdy SC; Jiang SW
Cell Signal; 2011 Jul; 23(7):1082-93. PubMed ID: 21345368
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation: a new research area for melatonin?
Korkmaz A; Reiter RJ
J Pineal Res; 2008 Jan; 44(1):41-4. PubMed ID: 18078446
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
Stirzaker C; Song JZ; Davidson B; Clark SJ
Cancer Res; 2004 Jun; 64(11):3871-7. PubMed ID: 15172996
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarker.
Tost J
Methods Mol Biol; 2009; 507():3-20. PubMed ID: 18987802
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic therapy in cancer: molecular background and clinical development of histone deacetylase and DNA methyltransferase inhibitors.
Schneider-Stock R; Ocker M
IDrugs; 2007 Aug; 10(8):557-61. PubMed ID: 17665331
[TBL] [Abstract][Full Text] [Related]
12. Targeting aberrant chromatin structure in colorectal carcinomas.
Konishi K; Issa JP
Cancer J; 2007; 13(1):49-55. PubMed ID: 17464246
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation or histone modification status in metastasis and angiogenesis-related genes: a new hypothesis on usage of DNMT inhibitors and S-adenosylmethionine for genome stability.
Sahin M; Sahin E; Gümüşlü S; Erdoğan A; Gültekin M
Cancer Metastasis Rev; 2010 Dec; 29(4):655-76. PubMed ID: 20821252
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic drugs take on cancer.
Kaiser J
Science; 2010 Oct; 330(6004):576-8. PubMed ID: 21030620
[No Abstract] [Full Text] [Related]
15. The potential role of epigenetic therapy in multiple myeloma.
Smith EM; Boyd K; Davies FE
Br J Haematol; 2010 Mar; 148(5):702-13. PubMed ID: 19912222
[TBL] [Abstract][Full Text] [Related]
16. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
Dobosy JR; Roberts JL; Fu VX; Jarrard DF
J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic changes in prostate cancer: implication for diagnosis and treatment.
Li LC; Carroll PR; Dahiya R
J Natl Cancer Inst; 2005 Jan; 97(2):103-15. PubMed ID: 15657340
[TBL] [Abstract][Full Text] [Related]
18. [Epigenome and cancer: new possibilities of cancer prevention and therapy?].
Paluszczak J; Baer-Dubowska W
Postepy Biochem; 2005; 51(3):244-50. PubMed ID: 16381168
[TBL] [Abstract][Full Text] [Related]
19. The dynamic epigenome and its implications in toxicology.
Szyf M
Toxicol Sci; 2007 Nov; 100(1):7-23. PubMed ID: 17675334
[TBL] [Abstract][Full Text] [Related]
20. Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead.
Mai A; Altucci L
Int J Biochem Cell Biol; 2009 Jan; 41(1):199-213. PubMed ID: 18790076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
